These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21460582)

  • 1. A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn.
    Abbott L; Grady C
    J Empir Res Hum Res Ethics; 2011 Mar; 6(1):3-19. PubMed ID: 21460582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
    Check DK; Weinfurt KP; Dombeck CB; Kramer JM; Flynn KE
    Clin Trials; 2013 Aug; 10(4):560-7. PubMed ID: 23666951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problematic variation in local institutional review of a multicenter genetic epidemiology study.
    McWilliams R; Hoover-Fong J; Hamosh A; Beck S; Beaty T; Cutting G
    JAMA; 2003 Jul; 290(3):360-6. PubMed ID: 12865377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability among institutional review boards' decisions within the context of a multicenter trial.
    Silverman H; Hull SC; Sugarman J
    Crit Care Med; 2001 Feb; 29(2):235-41. PubMed ID: 11246299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institutional Review Board Use of Outside Experts: What Do We Know?
    Serpico K; Rahimzadeh V; Anderson EE; Gelinas L; Lynch HF
    Ethics Hum Res; 2022 Mar; 44(2):26-32. PubMed ID: 35218600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform.
    Silberman G; Kahn KL
    Milbank Q; 2011 Dec; 89(4):599-627. PubMed ID: 22188349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research consent by adolescent minors and institutional review boards.
    Mammel KA; Kaplan DW
    J Adolesc Health; 1995 Nov; 17(5):323-30. PubMed ID: 8924437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional Review Boards: Purpose and Challenges.
    Grady C
    Chest; 2015 Nov; 148(5):1148-1155. PubMed ID: 26042632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking the camel's back: multicenter clinical trials and local institutional review boards.
    Burman WJ; Reves RR; Cohn DL; Schooley RT
    Ann Intern Med; 2001 Jan; 134(2):152-7. PubMed ID: 11177319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to facilitate institutional review board approval of multicenter research studies.
    Marsolo K
    Med Care; 2012 Jul; 50 Suppl():S77-81. PubMed ID: 22692264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operational Characteristics of Institutional Review Boards (IRBs) in the United States.
    Nesom GL; Petrof I; Moore TM
    AJOB Empir Bioeth; 2019; 10(4):276-286. PubMed ID: 31618119
    [No Abstract]   [Full Text] [Related]  

  • 12. Variation in institutional review board responses to a standard protocol for a multicenter clinical trial.
    Stair TO; Reed CR; Radeos MS; Koski G; Camargo CA;
    Acad Emerg Med; 2001 Jun; 8(6):636-41. PubMed ID: 11388939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Research in Vulnerable Populations: Variability and Focus of Institutional Review Boards' Responses.
    Kästner B; Behre S; Lutz N; Bürger F; Luntz S; Hinderhofer K; Bendszus M; Hoffmann GF; Ries M
    PLoS One; 2015; 10(8):e0135997. PubMed ID: 26275228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When IRBs Say No to Participating in Research about Single IRBs.
    Klitzman R; Appelbaum PS; Murray A; Pivovarova E; Stiles DF; Lidz CW
    Ethics Hum Res; 2020 Jan; 42(1):36-40. PubMed ID: 31967411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The investigator and the IRB: a survey of depression and schizophrenia researchers.
    Fischer BA; George P
    Schizophr Res; 2010 Sep; 122(1-3):206-12. PubMed ID: 20064703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in local institutional review board evaluations of a multicenter patient safety study.
    Thompson DA; Kass N; Holzmueller C; Marsteller JA; Martinez EA; Gurses AP; Kanchuger M; Schwann N; Gibson CS; Bauer L; Pronovost PJ
    J Healthc Qual; 2012; 34(4):33-9. PubMed ID: 22060010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of multicenter studies by multiple institutional review boards: characteristics and outcomes for perinatal studies implemented by a multicenter network.
    Abramovici A; Salazar A; Edvalson T; Gallagher N; Dorman K; Tita A;
    Am J Obstet Gynecol; 2015 Jan; 212(1):110.e1-6. PubMed ID: 25088862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How good does the science have to be in proposals submitted to Institutional Review Boards? An interview study of Institutional Review Board personnel.
    Klitzman R
    Clin Trials; 2013 Oct; 10(5):761-6. PubMed ID: 24000378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.